Owlet (OWLT) announced that the Central Drugs Standard Control Organization approved Dream Sock for distribution. This marks a significant milestone for the company as it now prepares to launch its integrated monitoring devices across India in early 2026. With approval from the CDSCO, India’s national regulatory body for cosmetics, pharmaceuticals, and medical devices, Owlet becomes one of the few infant health technology companies to meet the region’s medical device requirements.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OWLT: